Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition.

Allen A, Qin ACR, Raj N, Wang J, Uddin S, Yao Z, Tang L, Meyers PA, Taylor BS, Berger MF, Yaeger R, Reidy-Lagunes D, Pratilas CA.

PLoS One. 2019 Jun 3;14(6):e0217399. doi: 10.1371/journal.pone.0217399. eCollection 2019.

2.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.

Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N.

Eur J Cancer. 2019 Mar;109:36-50. doi: 10.1016/j.ejca.2018.11.027. Epub 2019 Jan 25.

3.

Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group.

Spraker-Perlman HL, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Doski J, Gorlick R, Janeway KA, Isakoff MS.

Pediatr Blood Cancer. 2019 Jan;66(1):e27444. doi: 10.1002/pbc.27444. Epub 2018 Sep 25.

PMID:
30255612
4.

Management of Patients with Acute Methotrexate Nephrotoxicity with High-Dose Leucovorin.

Flombaum CD, Liu D, Yan SQ, Chan A, Mathew S, Meyers PA, Glezerman IG, Muthukumar T.

Pharmacotherapy. 2018 Jun 4. doi: 10.1002/phar.2145. [Epub ahead of print]

PMID:
29863765
5.

DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas.

Wu SP, Cooper BT, Bu F, Bowman CJ, Killian JK, Serrano J, Wang S, Jackson TM, Gorovets D, Shukla N, Meyers PA, Pisapia DJ, Gorlick R, Ladanyi M, Thomas K, Snuderl M, Karajannis MA.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.17.00031. Epub 2017 Oct 6.

6.

Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.

Friedman DN, Chastain K, Chou JF, Moskowitz CS, Adsuar R, Wexler LH, Chou AJ, DeRosa A, Candela J, Magnan H, Pun S, Kahan T, Wolden SL, Meyers PA, Oeffinger KC.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26562. Epub 2017 Apr 18.

PMID:
28417551
7.

Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma.

Ortiz MV, Magnan H, Slotkin EK, Ambati SR, Chou AJ, Wexler LH, Meyers PA, Walsh MF, Heaton T, Girardi LN, Wolden SL, Price AP, Kennedy JA, Zehir A, Hameed M, Berger MF, Kentsis A, Shukla N.

J Pediatr Hematol Oncol. 2017 Nov;39(8):e443-e445. doi: 10.1097/MPH.0000000000000754.

8.

Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with EWSR1 fusion-positive sarcomas.

Shukla NN, Patel JA, Magnan H, Zehir A, You D, Tang J, Meng F, Samoila A, Slotkin EK, Ambati SR, Chou AJ, Wexler LH, Meyers PA, Peerschke EI, Viale A, Berger MF, Ladanyi M.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.16.00028. Epub 2017 May 23.

9.

A 20-year retrospective analysis of CT-based pre-operative identification of pulmonary metastases in patients with osteosarcoma: A single-center review.

Heaton TE, Hammond WJ, Farber BA, Pallos V, Meyers PA, Chou AJ, Price AP, LaQuaglia MP.

J Pediatr Surg. 2017 Jan;52(1):115-119. doi: 10.1016/j.jpedsurg.2016.10.034. Epub 2016 Oct 27.

10.

Rare presentation of Ewing sarcoma metastasis to the sella and suprasellar cistern.

Starc MT, Rosenblum MK, Meyers PA, Hatzoglou V.

Clin Imaging. 2017 Jan - Feb;41:73-77. doi: 10.1016/j.clinimag.2016.10.017. Epub 2016 Oct 20.

11.

A single-center experience with undifferentiated embryonal sarcoma of the liver.

Mathias MD, Ambati SR, Chou AJ, Slotkin EK, Wexler LH, Meyers PA, Magnan H.

Pediatr Blood Cancer. 2016 Dec;63(12):2246-2248. doi: 10.1002/pbc.26154. Epub 2016 Jul 18.

12.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS.

Lancet Oncol. 2016 Oct;17(10):1396-1408. doi: 10.1016/S1470-2045(16)30214-5. Epub 2016 Aug 25.

13.

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.

Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ.

Pediatr Blood Cancer. 2016 Oct;63(10):1737-43. doi: 10.1002/pbc.26034. Epub 2016 Apr 29.

14.

Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion.

Meyers PA.

Pediatr Blood Cancer. 2016 Feb;63(2):364. doi: 10.1002/pbc.25748. Epub 2015 Oct 21. No abstract available.

PMID:
26488216
15.

Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.

Yang R, Piperdi S, Zhang Y, Zhu Z, Neophytou N, Hoang BH, Mason G, Geller D, Dorfman H, Meyers PA, Healey JH, Phinney DG, Gorlick R.

Clin Orthop Relat Res. 2016 Jan;474(1):178-89.

16.

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.

Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE.

Pediatr Blood Cancer. 2016 Jan;63(1):54-61. doi: 10.1002/pbc.25753. Epub 2015 Sep 23.

17.

Identification of Discrete Prognostic Groups in Ewing Sarcoma.

Karski EE, McIlvaine E, Segal MR, Krailo M, Grier HE, Granowetter L, Womer RB, Meyers PA, Felgenhauer J, Marina N, DuBois SG.

Pediatr Blood Cancer. 2016 Jan;63(1):47-53. doi: 10.1002/pbc.25709. Epub 2015 Aug 10.

18.

Systemic therapy for osteosarcoma and Ewing sarcoma.

Meyers PA.

Am Soc Clin Oncol Educ Book. 2015:e644-7. doi: 10.14694/EdBook_AM.2015.35.e644. Review.

19.

Ewing sarcoma in adults treated with modern radiotherapy techniques.

Casey DL, Meyers PA, Alektiar KM, Magnan H, Healey JH, Boland PJ, Wolden SL.

Radiother Oncol. 2014 Nov;113(2):248-53. doi: 10.1016/j.radonc.2014.11.023. Epub 2014 Nov 26.

PMID:
25613397
20.

Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.

Daw NC, Chou AJ, Jaffe N, Rao BN, Billups CA, Rodriguez-Galindo C, Meyers PA, Huh WW.

Br J Cancer. 2015 Jan 20;112(2):278-82. doi: 10.1038/bjc.2014.585. Epub 2014 Nov 25.

21.

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M; EURAMOS collaborators.

Ann Oncol. 2015 Feb;26(2):407-14. doi: 10.1093/annonc/mdu526. Epub 2014 Nov 24.

22.

Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma.

Casey DL, Wexler LH, Meyers PA, Magnan H, Chou AJ, Wolden SL.

Pediatr Blood Cancer. 2015 Mar;62(3):445-9. doi: 10.1002/pbc.25294. Epub 2014 Oct 24.

23.

Whole-lung irradiation in the treatment of metastatic synovial sarcoma.

Gerber NK, Meyers PA, LaQuaglia MP, Wolden SL.

Pediatr Blood Cancer. 2014 Nov;61(11):2092-3. doi: 10.1002/pbc.25114. Epub 2014 Jun 17.

PMID:
24939451
24.

Muramyl tripeptide-phosphatidyl ethanolamine encapsulated in liposomes (L-MTP-PE) in the treatment of osteosarcoma.

Meyers PA, Chou AJ.

Adv Exp Med Biol. 2014;804:307-21. doi: 10.1007/978-3-319-04843-7_17. Review.

PMID:
24924182
25.

Particle Fluxes and Bulk Geochemical Characterization of the Cabo Frio Upwelling System in Southeastern Brazil: Sediment Trap Experiments between Spring 2010 and Summer 2012.

Albuquerque AL, Belém AL, Zuluaga FJ, Cordeiro LG, Mendoza U, Knoppers BA, Gurgel MH, Meyers PA, Capilla R.

An Acad Bras Cienc. 2014 Jun;86(2):601-620. Epub 2014 May 14.

26.

Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma.

Casey DL, Wexler LH, LaQuaglia MP, Meyers PA, Wolden SL.

Pediatr Blood Cancer. 2014 Sep;61(9):1565-9. doi: 10.1002/pbc.25088. Epub 2014 May 4.

PMID:
24798662
27.

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.

Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N.

Pediatr Blood Cancer. 2014 Sep;61(9):1558-64. doi: 10.1002/pbc.25074. Epub 2014 Apr 22.

28.

Patterns of failure for rhabdomyosarcoma of the perineal and perianal region.

Casey DL, Wexler LH, LaQuaglia MP, Meyers PA, Wolden SL.

Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):82-7. doi: 10.1016/j.ijrobp.2014.01.051.

PMID:
24725692
29.

Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?

Ulaner GA, Magnan H, Healey JH, Weber WA, Meyers PA.

AJR Am J Roentgenol. 2014 Apr;202(4):859-67. doi: 10.2214/AJR.13.11239.

PMID:
24660717
30.

Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma.

Ambati SR, Lopes EC, Kosugi K, Mony U, Zehir A, Shah SK, Taldone T, Moreira AL, Meyers PA, Chiosis G, Moore MA.

Mol Oncol. 2014 Mar;8(2):323-36. doi: 10.1016/j.molonc.2013.12.005. Epub 2013 Dec 15.

31.

Osteosarcoma treatment - where do we stand? A state of the art review.

Luetke A, Meyers PA, Lewis I, Juergens H.

Cancer Treat Rev. 2014 May;40(4):523-32. doi: 10.1016/j.ctrv.2013.11.006. Epub 2013 Nov 27. Review.

PMID:
24345772
32.

Quality of life following amputation or limb preservation in patients with lower extremity bone sarcoma.

Mason GE, Aung L, Gall S, Meyers PA, Butler R, Krüg S, Kim M, Healey JH, Gorlick R.

Front Oncol. 2013 Aug 14;3:210. doi: 10.3389/fonc.2013.00210. eCollection 2013.

33.

Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases.

Yang JC, Wexler LH, Meyers PA, Happersett L, La Quaglia MP, Wolden SL.

Pediatr Blood Cancer. 2013 Oct;60(10):1616-20. doi: 10.1002/pbc.24502. Epub 2013 Jun 13.

PMID:
23765910
34.

Pulmonary metastasectomy in pediatric/adolescent patients with synovial sarcoma: an institutional review.

Stanelle EJ, Christison-Lagay ER, Wolden SL, Meyers PA, La Quaglia MP.

J Pediatr Surg. 2013 Apr;48(4):757-63. doi: 10.1016/j.jpedsurg.2012.09.042.

PMID:
23583130
35.

Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.

Green DM, Kun LE, Matthay KK, Meadows AT, Meyer WH, Meyers PA, Spunt SL, Robison LL, Hudson MM.

Pediatr Blood Cancer. 2013 Jul;60(7):1083-94. doi: 10.1002/pbc.24487. Epub 2013 Feb 15. Review.

36.

Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung.

Chou AJ, Gupta R, Bell MD, Riewe KO, Meyers PA, Gorlick R.

Pediatr Blood Cancer. 2013 Apr;60(4):580-6. doi: 10.1002/pbc.24438. Epub 2012 Dec 19.

PMID:
23255417
37.

Positron emission tomography for response assessment in desmoplastic small round cell tumor.

Magnan H, Abramson SJ, Price AP, Grewal RK, Merchant MS, LaQuaglia MP, Meyers PA.

J Pediatr Hematol Oncol. 2013 Jul;35(5):e190-3. doi: 10.1097/MPH.0b013e3182707d4c.

PMID:
23073043
38.

Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors.

Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL.

J Clin Oncol. 2012 Nov 20;30(33):4141-7. doi: 10.1200/JCO.2012.44.1055. Epub 2012 Oct 15.

39.

Parameningeal rhabdomyosarcoma: outcomes and opportunities.

Yang JC, Wexler LH, Meyers PA, Wolden SL.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e61-6. doi: 10.1016/j.ijrobp.2012.08.019. Epub 2012 Sep 25.

PMID:
23021437
40.

Prognostic factors and survival in pediatric and adolescent liposarcoma.

Stanelle EJ, Christison-Lagay ER, Sidebotham EL, Singer S, Antonescu CR, Meyers PA, La Quaglia MP.

Sarcoma. 2012;2012:870910. Epub 2012 Sep 5.

41.

Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes.

Stanelle EJ, Christison-Lagay ER, Healey JH, Singer S, Meyers PA, La Quaglia MP.

Ann Surg Oncol. 2013 Jan;20(1):73-9. doi: 10.1245/s10434-012-2587-9. Epub 2012 Aug 10.

PMID:
22878620
42.

Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma.

Dharmarajan KV, Wexler LH, Gavane S, Fox JJ, Schoder H, Tom AK, Price AN, Meyers PA, Wolden SL.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):996-1002. doi: 10.1016/j.ijrobp.2012.01.077. Epub 2012 May 5.

PMID:
22560547
43.

Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.

Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N.

Cancer. 2012 Sep 15;118(18):4597-605. doi: 10.1002/cncr.27414. Epub 2012 Jan 17.

44.

R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study.

Pappo AS, Patel SR, Crowley J, Reinke DK, Kuenkele KP, Chawla SP, Toner GC, Maki RG, Meyers PA, Chugh R, Ganjoo KN, Schuetze SM, Juergens H, Leahy MG, Geoerger B, Benjamin RS, Helman LJ, Baker LH.

J Clin Oncol. 2011 Dec 1;29(34):4541-7. doi: 10.1200/JCO.2010.34.0000. Epub 2011 Oct 24.

45.

Addition of pamidronate to chemotherapy for the treatment of osteosarcoma.

Meyers PA, Healey JH, Chou AJ, Wexler LH, Merola PR, Morris CD, Laquaglia MP, Kellick MG, Abramson SJ, Gorlick R.

Cancer. 2011 Apr 15;117(8):1736-44. doi: 10.1002/cncr.25744. Epub 2010 Nov 8.

46.

Impairment of methotrexate transport is common in osteosarcoma tumor samples.

Sowers R, Wenzel BD, Richardson C, Meyers PA, Healey JH, Levy AS, Gorlick R.

Sarcoma. 2011;2011:834170. doi: 10.1155/2011/834170. Epub 2010 Dec 22.

47.

High-dose methotrexate-induced renal dysfunction: is glucarpidase necessary for rescue?

Meyers PA, Flombaum C.

J Clin Oncol. 2011 Mar 1;29(7):e180; author reply e181. doi: 10.1200/JCO.2010.32.8245. Epub 2011 Jan 10. No abstract available.

PMID:
21220601
48.

Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial.

Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, Priebat DA, Thomas DG, Jacobson JA, Samuels BL, Benjamin RS, Baker LH; Sarcoma Alliance for Research through Collaboration (SARC).

Clin Cancer Res. 2010 Oct 1;16(19):4884-91. doi: 10.1158/1078-0432.CCR-10-1177. Epub 2010 Aug 19.

49.

Ionizing radiation: an element of danger in every procedure.

Robbins E, Meyers PA.

Pediatr Blood Cancer. 2010 Sep;55(3):397-8. doi: 10.1002/pbc.22638. No abstract available.

PMID:
20658607
50.

Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study.

Ginsberg JP, Goodman P, Leisenring W, Ness KK, Meyers PA, Wolden SL, Smith SM, Stovall M, Hammond S, Robison LL, Oeffinger KC.

J Natl Cancer Inst. 2010 Aug 18;102(16):1272-83. doi: 10.1093/jnci/djq278. Epub 2010 Jul 23.

Supplemental Content

Loading ...
Support Center